In a surprising study, researchers at the University of California, Irvine, led by Professor Thomas Ahlering found that in a sample of carefully selected men who had low-risk prostate cancer and who had surgery, testosterone replacement therapy significantly lowered their risk for having a prostate cancer recurrence!
Stand Up To Cancer announced an initiative that will both help scientists understand the emerging coronavirus pandemic and ensure the needs of cancer patients and survivors are being included as the research goes forward.
